BACKGROUND/AIMS:The Barcelona Clinic Liver Cancer (BCLC) classification has been recently validated as the best system for treatment guidance for hepatocellular carcinoma (HCC), but it doesn't properly consider liver dysfunction. The aim of this retrospective study is to evaluate the usefulness of BCLC for hepatic surgeons comparing our treatment decision and BCLC algorithm indications.METHODOLOGY:A retrospective analysis of 102 patients affected by HCC observed from 1991 to 2002 was performed. The treatment choice was compared with the treatment schedule proposed by BCLC.RESULTS:Of 102 patients, in 44 (43.1%) cases, the present study treatment and BCLC system agreed, while in the remnant 58 (56.9%) cases, there was an under treatment in 47 (81.1%) patients and an overtreatment in 11 (18.9%). About the undertreatment cases we didn't perform hepatic resection such as BCLC suggests because of advanced age and/or high level of IGC; in patients in whom BCLC would suggest chemoembolization, we supposed this treatment as high risk therapy. Regarding the overtreatment, we choose hepatic resection, because early Child B class and good liver functional status.CONCLUSIONS:Analysing our aprroach in the treatment of HCC during ten years before introduction of BCLC classification, we can conclude that even if our treatment choice disagreed with BCLC systems, this wouldn't changed our decision especially in surgical indications.

Background. The Barcelona Clinic Liver Cancer (BCLC) classification has been recently validated as the best system for treatment guidance for hepatocellular carcinoma (HCC). Aims. The aim of this retrospective study is to evaluate the usefulness of BCLC in the treatment of HCC comparing our treatment decision and the BCLC algorithm indications. Methods. In 102 patients affected by HCC observed from 1991 to 2002 a retrospective analysis was performed. The choice of treatment was compared with the treatment schedule proposed by BCLC. Whereas the second group of 62 patients observed from 2008 to 2010 was analysed both retrospectively in comparison with the BCLC classification. Results. We found a disagreement in between our decision making and the choices suggested by BCLC. We only found a statistical significance for age and performance status test (PST). In surgical patients the median age and the PST class were lower with a statistically significative p value (0.04 and 0.03 respectively). Conclusion. The BCLC system would have not changed our decision either in the past, or in present days, especially in surgical indications. Even if the decision making is affected by BCLC, actually that process still needs the support of the experience of each clinical centre involved.

Analysis of BCLC treatment indications. Have BCLC modified our choice of treatment in HCC patients? A retrospective study

LA GRECA, Gaetano;PORTALE, Teresa Rosanna;RUSSELLO, Domenico;PULEO, Stefano
2009-01-01

Abstract

Background. The Barcelona Clinic Liver Cancer (BCLC) classification has been recently validated as the best system for treatment guidance for hepatocellular carcinoma (HCC). Aims. The aim of this retrospective study is to evaluate the usefulness of BCLC in the treatment of HCC comparing our treatment decision and the BCLC algorithm indications. Methods. In 102 patients affected by HCC observed from 1991 to 2002 a retrospective analysis was performed. The choice of treatment was compared with the treatment schedule proposed by BCLC. Whereas the second group of 62 patients observed from 2008 to 2010 was analysed both retrospectively in comparison with the BCLC classification. Results. We found a disagreement in between our decision making and the choices suggested by BCLC. We only found a statistical significance for age and performance status test (PST). In surgical patients the median age and the PST class were lower with a statistically significative p value (0.04 and 0.03 respectively). Conclusion. The BCLC system would have not changed our decision either in the past, or in present days, especially in surgical indications. Even if the decision making is affected by BCLC, actually that process still needs the support of the experience of each clinical centre involved.
BACKGROUND/AIMS:The Barcelona Clinic Liver Cancer (BCLC) classification has been recently validated as the best system for treatment guidance for hepatocellular carcinoma (HCC), but it doesn't properly consider liver dysfunction. The aim of this retrospective study is to evaluate the usefulness of BCLC for hepatic surgeons comparing our treatment decision and BCLC algorithm indications.METHODOLOGY:A retrospective analysis of 102 patients affected by HCC observed from 1991 to 2002 was performed. The treatment choice was compared with the treatment schedule proposed by BCLC.RESULTS:Of 102 patients, in 44 (43.1%) cases, the present study treatment and BCLC system agreed, while in the remnant 58 (56.9%) cases, there was an under treatment in 47 (81.1%) patients and an overtreatment in 11 (18.9%). About the undertreatment cases we didn't perform hepatic resection such as BCLC suggests because of advanced age and/or high level of IGC; in patients in whom BCLC would suggest chemoembolization, we supposed this treatment as high risk therapy. Regarding the overtreatment, we choose hepatic resection, because early Child B class and good liver functional status.CONCLUSIONS:Analysing our aprroach in the treatment of HCC during ten years before introduction of BCLC classification, we can conclude that even if our treatment choice disagreed with BCLC systems, this wouldn't changed our decision especially in surgical indications.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/26452
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact